From computational screening to zebrafish testing: repurposing of doxazosin, donepezil, and dolutegravir for neuroprotective potential in Alzheimer’s disease
- 27 February 2025
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (8) , 10581-10595
Abstract
Amyloid-beta (Aß) plaques and neurofibrillary tangles are distinctive features of Alzheimer’s disease (AD), a progressive disorder that results in considerable memory loss and decline in cognitive function. Presently available therapies, such as donepezil and other medications that inhibit acetylcholinesterase, mainly provide relief from symptoms but do not change the course of the disease. This research article intends to investigate the possible reuse of two FDA-approved medications, doxazosin and dolutegravir, discovered through computerized screening using shape similarity, docking energy, and molecular dynamics stability, for the purpose of targeting human acetylcholinesterase (AChE) in the development of disease-altering treatments. In order to mimic neurotoxicity similar to Alzheimer’s disease, zebrafish (Danio rerio) were treated with aluminum chloride (AlCl3). Various behavioral assessments, such as the open field test, mirror biting test, novel tank test, social preference test, and dark–light preference test, were carried out to assess cognitive function, movement, and anxiety-related behaviors. The results indicated that doxazosin, a drug that blocks alpha-1 adrenergic receptors, successfully decreased neuroinflammation and improved cognitive abilities. Additionally, dolutegravir, which is mainly used as an antiviral medication, showed notable benefits in protecting the nervous system. This study highlights the possibility of using doxazosin and dolutegravir as effective alternative treatments for Alzheimer’s disease. Upcoming preclinical and clinical research is necessary to confirm the safety and effectiveness of AD treatment, paving the way for new opportunities in therapeutic intervention.Keywords
This publication has 25 references indexed in Scilit:
- Zebrafish: A Pharmacological Model for Learning and Memory ResearchMolecules, 2022
- AlCl3 induced learning and memory deficit in zebrafishNeuroToxicology, 2022
- Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experienceFrontiers in Neuroscience, 2021
- Social Preference Tests in Zebrafish: A Systematic ReviewFrontiers in Veterinary Science, 2021
- Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?Frontiers in Neuroscience, 2020
- An Automated Assay System to Study Novel Tank Induced AnxietyFrontiers in Behavioral Neuroscience, 2019
- Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's DiseaseNeuroscience, 2019
- Drugs in Clinical Trials for Alzheimer's Disease: The Major TrendsMedicinal Research Reviews, 2017
- Zebrafish as tools for drug discoveryNature Reviews Drug Discovery, 2015
- Understanding spatio-temporal strategies of adult zebrafish exploration in the open field testBrain Research, 2012